Search
for
Sort by
Research 781–810 of 1000+
- Nutrition and Hair
- Primary cicatricial alopecia
- Nutritional management in women with polycystic ovary syndrome: A review study
- Obesity and polycystic ovary syndrome
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Polycystic Ovarian Syndrome
- Health and fertility in World Health Organization group 2 anovulatory women
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Phospholipase A2 Is Required for PIN-FORMED Protein Trafficking to the Plasma Membrane in the<i>Arabidopsis</i>Root
- Safety of testosterone treatment in postmenopausal women
- Elastic tissue in scars and alopecia
- Multidisciplinary treatment of obesity with a protein-sparing modified fast: results in 668 outpatients.
- Sequelae of COVID-19 among previously hospitalized patients up to 1 year after discharge: a systematic review and meta-analysis
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome (PCOS): A Six-Month, Open-Label Randomized Study
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Insulin Resistance and Skin Diseases
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- PCOS in adolescents
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Replicative stress, stem cells and aging
- Dermatology of androgen-related disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial